Covered recipient · General Payments record
PATRICIA MARY MILNER
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2020–2022
$705.48
- Reported across 37 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $165.50 | 9 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $56.96 | 3 |
| Neurocrine BioSciences, Inc. | $21.19 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.22 | 1 |
| Otsuka America Pharmaceutical, Inc. | $19.33 | 1 |
| Indivior Inc. | $17.44 | 1 |
| JAZZ PHARMACEUTICALS INC. | $15.56 | 1 |
| Lundbeck LLC | $14.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Indivior Inc. | $17.44 | 03/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 914480615 | CMS |
| Janssen Pharmaceuticals, Inc | $18.76 | 03/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 886445489 | CMS |
| Janssen Pharmaceuticals, Inc | $19.33 | 04/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 886445477 | CMS |
| Janssen Pharmaceuticals, Inc | $18.87 | 10/31/2022 | Food and Beverage | Undisputed | 01/23/2026 | 886445483 | CMS |
| JAZZ PHARMACEUTICALS INC. | $15.56 | 01/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 951332757 | CMS |
| Lundbeck LLC | $14.80 | 02/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 945780303 | CMS |
| Neurocrine Biosciences, Inc. | $21.19 | 01/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 963333003 | CMS |
| Otsuka America Pharmaceutical, Inc. | $19.33 | 02/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 929315177 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.22 | 01/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 955736913 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022
- Source files
- Dataset page · Bulk file · PY2020 , PY2021 , PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.